Key result
Reduced LVEF links to ~7-fold higher heart failure hospitalization risk after Micra VR implantation.
Why the study?
Although the Micra VR leadless pacemaker has high effectiveness and a lower complication rate than conventional transvenous pacemakers, little was known about the incidence and predictors of heart failure hospitalization after de novo Micra VR implantation.
What are the incidence and independent predictors of heart failure hospitalization in elderly patients with symptomatic bradycardia undergoing de novo Micra VR leadless pacemaker implantation?
Cohort (n=94)
No
What are the incidence and independent predictors of heart failure hospitalization in elderly patients with symptomatic bradycardia undergoing de novo Micra VR leadless pacemaker implantation?
In very elderly patients receiving a Micra VR leadless pacemaker, a history of atrial fibrillation and baseline LVEF ≤50% are strong independent predictors of subsequent heart failure hospitalization, suggesting this single-chamber device is best suited for patients with preserved LVEF and no prior AF.
Answers are grounded in this paper and cite their sources.
AF history and reduced LVEF were associated with higher HF hospitalization after Micra VR; hypothesis-generating for selection, needs prospective confirmation.
Introduction Micra VR, the first leadless pacemaker, offers a high effectiveness and lower complication rate than conventional transvenous pacemakers. However, little is known about heart failure hospitalization after Micra VR implantation. We investigated the incidence and predictors of heart failure hospitalization in patients who underwent de novo Micra VR implantations. Methods Ninety-four consecutive patients who underwent de novo Micra VR implantation (mean age 84.6±6.9 years, 45 males) were enrolled. Clinical outcomes were evaluated during follow-up, and predictors of heart failure hospitalization were assessed. Results During the mean follow-up period of 640±392 days, 17 (18.1%) patients were hospitalized due to heart failure post-implantations. Heart failure hospitalization was associated with a history of atrial fibrillation and reduced left ventricular ejection fraction (LVEF≤50%). Multivariate analysis revealed that a history of AF (hazard ratio [HR], 5.77; 95% confidence interval [CI], 1.64–20.3; P = 0.006) and reduced LVEF (LVEF≤50%) (HR, 7.04; 95% CI, 1.89–26.2; P = 0.004) were independent risk factors for heart failure hospitalization. hospitalization. Conclusion The presence of AF history and reduced LVEF were predictors of heart failure hospitalization in patients with Micra VR.
No takes yet. Share an insight, caveat, or question.
Matsumura et al. (2026) conducted a cohort in Symptomatic bradycardia treated with de novo Micra VR leadless pacemaker (n=94). Reduced left ventricular ejection fraction (LVEF <=50%) vs. Normal left ventricular ejection fraction (LVEF >50%) was evaluated on First hospitalization for acute decompensated heart failure (ADHF) after Micra VR implantation (HR 7.04, 95% CI 1.89-26.2, p=0.004). Reduced LVEF and a history of atrial fibrillation independently increased heart failure hospitalization risk after Micra VR implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: